A retrospective study evaluating clinical course of biliary tract cancer and its prognostic factors with the standard gemcitabine plus cisplatin treatment.

Trial Profile

A retrospective study evaluating clinical course of biliary tract cancer and its prognostic factors with the standard gemcitabine plus cisplatin treatment.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2017

At a glance

  • Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
  • Indications Adenocarcinoma; Biliary cancer; Carcinoma; Cholangiocarcinoma; Gallbladder cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Aug 2017 New trial record
    • 01 Jul 2017 Results published in the Cancer Chemotherapy and Pharmacology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top